Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Schmidt (Muenster, Germany), C. Brand (Muenster, Germany), J. Stucke-Ring (Muenster, Germany), S. Harrach (Muenster, Germany), C. Schliemann (Muenster, Germany), A. Marra (Bremen, Germany), L. Hillejan (Ostercappeln, Germany), C. Mueller-Tidow (Heidelberg, Germany), G. Lenz (Muenster, Germany), E. Wardelmann (Muenster, Germany), R. Wiewrodt (Muenster, Germany), T. Muley (Heidelberg, Germany), E. Herpel (Heidelberg, Germany), M. Mohr (Muenster, Germany), D. Goerlich (Muenster, Germany), M. Kreuter (Heidelberg, Germany), M. Thomas (Heidelberg, Germany), C. Schwoeppe (Muenster, Germany), W. Hartmann (Muenster, Germany), W. Berdel (Muenster, Germany). Tissue factor induced tumor vascular infarction in lung cancer. 2846

Member's Comments

No comment yet.

Related content which might interest you: Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Vascular endothelial growth factor in sera of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 330s Year: 2005 Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Apoptosis, tumor cell proliferation and angiogenesis as prognostic factor in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Expression of vascular endothelial-cadherin and vascular endothelial growth factor in non-small cell lung cancer and their clinical significances Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 The impact of thrombosis events in excised tumor tissues on the prognosis of non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005 Vascular endothelial growth factor and oxidative stress in patients with primary lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Epidermal growth factor receptor and related biomarkers evaluated by immunohistochemistry in patients with resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Inverse correlation between the expression of vascular endothelial growth factor and infiltration of dendritic cells and their influence on the prognosis of nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 13s Year: 2002 Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Vascular endothelial growth factor C is a predictor of early recurrence and poor prognosis of resected stage I non-small cell lung cancer in Taiwan Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019 Connective tissue disease-related interstitial lung disease and lung cancer Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Role of interferon-γ in tumor necrosis factor-α-mediated increase of lung microvascular endothelial cells Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Serum angiopoietins as a clinical marker for resected early lung cancer Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008